|
|
|
Real Estate News Releases
|
(EMAILWIRE.COM, November 06, 2011 ) Belize City, Belize -- Publishers of daily newsletter xtremepicks.com (http://www.xtremepicks.com) looks at Burzynski Research (BZYR) and Fuse Science (DROP).
Congrats to xtremepicks.com's members of a huge winning week and those who held on to their long term picks, DROP (DEGH), and BZYR which made solid gains this week.
DEGH is already Xtremepicks.com's huge 50,000% gainer from their initial alert at $0.0014 which hit their $0.75 target level earlier this year. Members who jump on their re-alert at $0.15 a few weeks back, is sitting nicely on 150% gains.
The key to these plays and all xtremepicks.com's long term picks is patience, and scooping up cheap shares on any minor pull backs as mega rewards will follow.
DEGH, and BZYR is locked and loaded for much more gains next week as members look towards updates that is set to skyrocket prices.
FUSE SCIENCE (DROP)
**Please note: Otcbb.com listed a symbol change for DEGH to DROP effective November 3, 2011***
All eyes will be on Poker Pro Matt Giannetti who is now “Powered by Fuse” and will be heading to the World Series of Poker final table in Las Vegas – the exposure for DROP will be monsterous and everyone will know what Fuse is all about.
DROP closed at $0.37, rallying up 68% and headed straight for dollar land. With the exposure of the World Series of Poker, next week will definitely be a wild week for DROP.
Technicals are also setting up for a monster breakout with a golden cross formation confirmed- a strong bullish signal headed for much higher prices.
Powered by Fuse, Poker Pro Matt Giannetti Makes Final Table at 2011 World Series of Poker Main Event
Double Eagle Holdings, Ltd. (OTCQB: DROP), the parent company of Fuse Science, Inc. (www.fusescience.com), announced today that poker pro Matt Giannetti will be “Powered by Fuse” as he seeks his first World Series of Poker title, beginning this Sunday, November 6, at 3:30 p.m. EST and airing live from Las Vegas on ESPN2.About Fuse Science, Inc.
(Logo: http://photos.prnewswire.com/prnh/20110615/CL20255LOGO )
Fuse Science is the developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. Giannetti will be using EnerJel, Fuse ScienceÂ’s proprietary energy delivery system, to keep his focus and energy during the tournament. He will continue to use EnerJel while at the Main Event final table and will be seen by millions showcasing the EnerJel product as his card protector.
“With EnerJel, it’s no question. I feel the burst of energy in just seconds as opposed to a half hour or more with the standard energy drinks and shots,” said Giannetti. “EnerJel will help me keep my focus throughout the tournament, and its all-natural healthy boost of energy is exactly what I need. I can’t worry about getting the jitters from downing an energy drink. My focus will solely be on winning this event; I can’t let fatigue get in the way.”
EnerJel addresses site-specific muscle fatigue while simultaneously delivering a powerfully effective, all-natural energy boost throughout the entire body. Using Fuse ScienceÂ’s breakthrough delivery technology, EnerJel penetrates dermal layers immediately to deliver lasting energy so athletes can stay in the game longer, faster and stronger.
“Poker is a game that lends itself to many unhealthy habits and whose top stars often sit very still for hours on end,” added Adam Adler, Fuse Science Chief Executive Officer. “It is a world where sugary energy drinks are the norm, but Matt has chosen the healthy alternative in EnerJel to keep him going. He is proof that for the first time, consumers have an all-natural product with an innovative delivery technology that produces virtually immediate, long-lasting results.” EnerJel will be launched to the public later this month Online at www.poweredbyfuse.com.
Giannetti, 26, attended the University of Texas and is fresh from a victory at the World Poker Tour Malta where he earned $276,457 just five weeks ago. He is a seasoned high-stakes poker player with one previous cash in a World Series of Poker Main Event and more than $500,000 in total World Series of Poker earnings since 2006. As a member of this year’s November Nine, he is guaranteed at least $782,155. Giannetti enters the Main Event final table third in chips with 24,750,000 – and in excellent position to take the $8.7 million grand prize – after quadrupling his stack on the final table bubble.
Following ESPN2′s Sunday afternoon broadcast, live coverage of the World Series of Poker Main Event resumes at 11:30 p.m. EST that evening, also on ESPN2. The Main Event continues Tuesday, November 8, beginning at 9:00 p.m. EST and airing live on ESPN.
Fuse Science, Inc. (OTCQB: DROP) is an innovative consumer products company based in Aventura, Florida. Fuse ScienceÂ’s proprietary delivery and conveyance technologies are poised to redefine how consumers receive energy, medicines, vitamins and minerals, delivering their benefits faster and more effectively than ever before. Information about Fuse Science is available online at www.fusescience.com or by calling 305-503-FUSE (3873).
BURZYNSKI RESEARCH
If thereÂ’s ever a hint that something big is ready to be unleashed it is how BZYR traded this week as smart accumulation pushed prices to its all-time high.
Watch the MUST SEE BZYRÂ’s Video that shows its amazing Cancer treatment.
The video can be viewed at http://vimeo.com/24821365
Xtremepicks.com anticipates the company is near releasing a big update on their cancer treatment and if the company announces FDA approval, BZYR can move like wildfire. All bets are off where this can head to.
FDA approval of national distribution and administration of their treatment can be worth billions for BZYR!
BZYR closed at $0.30 and at an all-time high. Volumes have been much higher than normal with all signals pointing to a breakout. With mega news expected, BZYR can really heat up.
How much would a Cure for Cancer be worth?
Concentrate that into a company, valuations can go off the charts.
BZYR already presented data to back up their claims that their treatment in cancer patients resulted in overwhelming success.
Dr. Burzynski of BZYR stresses that he has the solution to treat and cure Cancer patients and have the research and results to back up his claims. Dr. Burzynski also invested millions of his own funds in the company, definitely showing commitment to his “Cancer Cure”.
With more clinical trials and seeking FDA approval of national distribution and administration of their treatment, BZYR is presenting an amazing opportunity with huge upside potential.
Burzynski Research Institute (BRI), a biopharmaceutical company committed to developing treatment for cancer based on genomic and epigenomic principles. Research and developmental efforts are focused on cancer treatment with two pipeline drugs—antineoplastons (ANP) in one Phase III clinical trial and 5 Phase II clinical trials. Two additional Phase III trials are being discussed with the FDA. The ultimate goal of the BRI is to discover, develop, and obtain the FDA’s marketing approval of ANP for the treatment of currently incurable types of cancer with emphasis on malignant brain tumors in adults and children.
About Xtremepicks.com
Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. Xtremepicks.com provide market awareness services for small to mid-cap stocks with daily and special newsletters to keep you informed of the latest movers.
Xtremepicks.com penny stock newsletter is your trading connection and remember to always do your own research, use stop loss orders to protect yourself, and book your profits when in a position to do so.
Xtremepicks.com penny stock newsletter profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do your own due diligence. Xtremepicks did not receive any compensation for IFHR and at times may buy any features in the open market. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved
Directglobalmedia.com
Max Gordon
6479227508
contact@directglobalmedia.com 
(EMAILWIRE.COM, November 06, 2011 ) Belize City, Belize -- Publishers of daily newsletter xtremepicks.com (http://www.xtremepicks.com) looks at Burzynski Research (BZYR) and Fuse Science (DROP).
Congrats to xtremepicks.com's members of a huge winning week and those who held on to their long term picks, DROP (DEGH), and BZYR which made solid gains this week.
DEGH is already Xtremepicks.com's huge 50,000% gainer from their initial alert at $0.0014 which hit their $0.75 target level earlier this year. Members who jump on their re-alert at $0.15 a few weeks back, is sitting nicely on 150% gains.
The key to these plays and all xtremepicks.com's long term picks is patience, and scooping up cheap shares on any minor pull backs as mega rewards will follow.
DEGH, and BZYR is locked and loaded for much more gains next week as members look towards updates that is set to skyrocket prices.
FUSE SCIENCE (DROP)
**Please note: Otcbb.com listed a symbol change for DEGH to DROP effective November 3, 2011***
All eyes will be on Poker Pro Matt Giannetti who is now “Powered by Fuse” and will be heading to the World Series of Poker final table in Las Vegas – the exposure for DROP will be monsterous and everyone will know what Fuse is all about.
DROP closed at $0.37, rallying up 68% and headed straight for dollar land. With the exposure of the World Series of Poker, next week will definitely be a wild week for DROP.
Technicals are also setting up for a monster breakout with a golden cross formation confirmed- a strong bullish signal headed for much higher prices.
Powered by Fuse, Poker Pro Matt Giannetti Makes Final Table at 2011 World Series of Poker Main Event
Double Eagle Holdings, Ltd. (OTCQB: DROP), the parent company of Fuse Science, Inc. (www.fusescience.com), announced today that poker pro Matt Giannetti will be “Powered by Fuse” as he seeks his first World Series of Poker title, beginning this Sunday, November 6, at 3:30 p.m. EST and airing live from Las Vegas on ESPN2.About Fuse Science, Inc.
(Logo: http://photos.prnewswire.com/prnh/20110615/CL20255LOGO )
Fuse Science is the developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. Giannetti will be using EnerJel, Fuse ScienceÂ’s proprietary energy delivery system, to keep his focus and energy during the tournament. He will continue to use EnerJel while at the Main Event final table and will be seen by millions showcasing the EnerJel product as his card protector.
“With EnerJel, it’s no question. I feel the burst of energy in just seconds as opposed to a half hour or more with the standard energy drinks and shots,” said Giannetti. “EnerJel will help me keep my focus throughout the tournament, and its all-natural healthy boost of energy is exactly what I need. I can’t worry about getting the jitters from downing an energy drink. My focus will solely be on winning this event; I can’t let fatigue get in the way.”
EnerJel addresses site-specific muscle fatigue while simultaneously delivering a powerfully effective, all-natural energy boost throughout the entire body. Using Fuse ScienceÂ’s breakthrough delivery technology, EnerJel penetrates dermal layers immediately to deliver lasting energy so athletes can stay in the game longer, faster and stronger.
“Poker is a game that lends itself to many unhealthy habits and whose top stars often sit very still for hours on end,” added Adam Adler, Fuse Science Chief Executive Officer. “It is a world where sugary energy drinks are the norm, but Matt has chosen the healthy alternative in EnerJel to keep him going. He is proof that for the first time, consumers have an all-natural product with an innovative delivery technology that produces virtually immediate, long-lasting results.” EnerJel will be launched to the public later this month Online at www.poweredbyfuse.com.
Giannetti, 26, attended the University of Texas and is fresh from a victory at the World Poker Tour Malta where he earned $276,457 just five weeks ago. He is a seasoned high-stakes poker player with one previous cash in a World Series of Poker Main Event and more than $500,000 in total World Series of Poker earnings since 2006. As a member of this year’s November Nine, he is guaranteed at least $782,155. Giannetti enters the Main Event final table third in chips with 24,750,000 – and in excellent position to take the $8.7 million grand prize – after quadrupling his stack on the final table bubble.
Following ESPN2′s Sunday afternoon broadcast, live coverage of the World Series of Poker Main Event resumes at 11:30 p.m. EST that evening, also on ESPN2. The Main Event continues Tuesday, November 8, beginning at 9:00 p.m. EST and airing live on ESPN.
Fuse Science, Inc. (OTCQB: DROP) is an innovative consumer products company based in Aventura, Florida. Fuse ScienceÂ’s proprietary delivery and conveyance technologies are poised to redefine how consumers receive energy, medicines, vitamins and minerals, delivering their benefits faster and more effectively than ever before. Information about Fuse Science is available online at www.fusescience.com or by calling 305-503-FUSE (3873).
BURZYNSKI RESEARCH
If thereÂ’s ever a hint that something big is ready to be unleashed it is how BZYR traded this week as smart accumulation pushed prices to its all-time high.
Watch the MUST SEE BZYRÂ’s Video that shows its amazing Cancer treatment.
The video can be viewed at http://vimeo.com/24821365
Xtremepicks.com anticipates the company is near releasing a big update on their cancer treatment and if the company announces FDA approval, BZYR can move like wildfire. All bets are off where this can head to.
FDA approval of national distribution and administration of their treatment can be worth billions for BZYR!
BZYR closed at $0.30 and at an all-time high. Volumes have been much higher than normal with all signals pointing to a breakout. With mega news expected, BZYR can really heat up.
How much would a Cure for Cancer be worth?
Concentrate that into a company, valuations can go off the charts.
BZYR already presented data to back up their claims that their treatment in cancer patients resulted in overwhelming success.
Dr. Burzynski of BZYR stresses that he has the solution to treat and cure Cancer patients and have the research and results to back up his claims. Dr. Burzynski also invested millions of his own funds in the company, definitely showing commitment to his “Cancer Cure”.
With more clinical trials and seeking FDA approval of national distribution and administration of their treatment, BZYR is presenting an amazing opportunity with huge upside potential.
Burzynski Research Institute (BRI), a biopharmaceutical company committed to developing treatment for cancer based on genomic and epigenomic principles. Research and developmental efforts are focused on cancer treatment with two pipeline drugs—antineoplastons (ANP) in one Phase III clinical trial and 5 Phase II clinical trials. Two additional Phase III trials are being discussed with the FDA. The ultimate goal of the BRI is to discover, develop, and obtain the FDA’s marketing approval of ANP for the treatment of currently incurable types of cancer with emphasis on malignant brain tumors in adults and children.
About Xtremepicks.com
Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. Xtremepicks.com provide market awareness services for small to mid-cap stocks with daily and special newsletters to keep you informed of the latest movers.
Xtremepicks.com penny stock newsletter is your trading connection and remember to always do your own research, use stop loss orders to protect yourself, and book your profits when in a position to do so.
Xtremepicks.com penny stock newsletter profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do your own due diligence. Xtremepicks did not receive any compensation for IFHR and at times may buy any features in the open market. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved
Directglobalmedia.com
Max Gordon
6479227508
contact@directglobalmedia.com
(EMAILWIRE.COM, November 06, 2011 ) Belize City, Belize -- Publishers of daily newsletter xtremepicks.com (http://www.xtremepicks.com) looks at Burzynski Research (BZYR) and Fuse Science (DROP).
Congrats to xtremepicks.com's members of a huge winning week and those who held on to their long term picks, DROP (DEGH), and BZYR which made solid gains this week.
DEGH is already Xtremepicks.com's huge 50,000% gainer from their initial alert at $0.0014 which hit their $0.75 target level earlier this year. Members who jump on their re-alert at $0.15 a few weeks back, is sitting nicely on 150% gains.
The key to these plays and all xtremepicks.com's long term picks is patience, and scooping up cheap shares on any minor pull backs as mega rewards will follow.
DEGH, and BZYR is locked and loaded for much more gains next week as members look towards updates that is set to skyrocket prices.
FUSE SCIENCE (DROP)
**Please note: Otcbb.com listed a symbol change for DEGH to DROP effective November 3, 2011***
All eyes will be on Poker Pro Matt Giannetti who is now “Powered by Fuse” and will be heading to the World Series of Poker final table in Las Vegas – the exposure for DROP will be monsterous and everyone will know what Fuse is all about.
DROP closed at $0.37, rallying up 68% and headed straight for dollar land. With the exposure of the World Series of Poker, next week will definitely be a wild week for DROP.
Technicals are also setting up for a monster breakout with a golden cross formation confirmed- a strong bullish signal headed for much higher prices.
Powered by Fuse, Poker Pro Matt Giannetti Makes Final Table at 2011 World Series of Poker Main Event
Double Eagle Holdings, Ltd. (OTCQB: DROP), the parent company of Fuse Science, Inc. (www.fusescience.com), announced today that poker pro Matt Giannetti will be “Powered by Fuse” as he seeks his first World Series of Poker title, beginning this Sunday, November 6, at 3:30 p.m. EST and airing live from Las Vegas on ESPN2.About Fuse Science, Inc.
(Logo: http://photos.prnewswire.com/prnh/20110615/CL20255LOGO )
Fuse Science is the developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. Giannetti will be using EnerJel, Fuse ScienceÂ’s proprietary energy delivery system, to keep his focus and energy during the tournament. He will continue to use EnerJel while at the Main Event final table and will be seen by millions showcasing the EnerJel product as his card protector.
“With EnerJel, it’s no question. I feel the burst of energy in just seconds as opposed to a half hour or more with the standard energy drinks and shots,” said Giannetti. “EnerJel will help me keep my focus throughout the tournament, and its all-natural healthy boost of energy is exactly what I need. I can’t worry about getting the jitters from downing an energy drink. My focus will solely be on winning this event; I can’t let fatigue get in the way.”
EnerJel addresses site-specific muscle fatigue while simultaneously delivering a powerfully effective, all-natural energy boost throughout the entire body. Using Fuse ScienceÂ’s breakthrough delivery technology, EnerJel penetrates dermal layers immediately to deliver lasting energy so athletes can stay in the game longer, faster and stronger.
“Poker is a game that lends itself to many unhealthy habits and whose top stars often sit very still for hours on end,” added Adam Adler, Fuse Science Chief Executive Officer. “It is a world where sugary energy drinks are the norm, but Matt has chosen the healthy alternative in EnerJel to keep him going. He is proof that for the first time, consumers have an all-natural product with an innovative delivery technology that produces virtually immediate, long-lasting results.” EnerJel will be launched to the public later this month Online at www.poweredbyfuse.com.
Giannetti, 26, attended the University of Texas and is fresh from a victory at the World Poker Tour Malta where he earned $276,457 just five weeks ago. He is a seasoned high-stakes poker player with one previous cash in a World Series of Poker Main Event and more than $500,000 in total World Series of Poker earnings since 2006. As a member of this year’s November Nine, he is guaranteed at least $782,155. Giannetti enters the Main Event final table third in chips with 24,750,000 – and in excellent position to take the $8.7 million grand prize – after quadrupling his stack on the final table bubble.
Following ESPN2′s Sunday afternoon broadcast, live coverage of the World Series of Poker Main Event resumes at 11:30 p.m. EST that evening, also on ESPN2. The Main Event continues Tuesday, November 8, beginning at 9:00 p.m. EST and airing live on ESPN.
Fuse Science, Inc. (OTCQB: DROP) is an innovative consumer products company based in Aventura, Florida. Fuse ScienceÂ’s proprietary delivery and conveyance technologies are poised to redefine how consumers receive energy, medicines, vitamins and minerals, delivering their benefits faster and more effectively than ever before. Information about Fuse Science is available online at www.fusescience.com or by calling 305-503-FUSE (3873).
BURZYNSKI RESEARCH
If thereÂ’s ever a hint that something big is ready to be unleashed it is how BZYR traded this week as smart accumulation pushed prices to its all-time high.
Watch the MUST SEE BZYRÂ’s Video that shows its amazing Cancer treatment.
The video can be viewed at http://vimeo.com/24821365
Xtremepicks.com anticipates the company is near releasing a big update on their cancer treatment and if the company announces FDA approval, BZYR can move like wildfire. All bets are off where this can head to.
FDA approval of national distribution and administration of their treatment can be worth billions for BZYR!
BZYR closed at $0.30 and at an all-time high. Volumes have been much higher than normal with all signals pointing to a breakout. With mega news expected, BZYR can really heat up.
How much would a Cure for Cancer be worth?
Concentrate that into a company, valuations can go off the charts.
BZYR already presented data to back up their claims that their treatment in cancer patients resulted in overwhelming success.
Dr. Burzynski of BZYR stresses that he has the solution to treat and cure Cancer patients and have the research and results to back up his claims. Dr. Burzynski also invested millions of his own funds in the company, definitely showing commitment to his “Cancer Cure”.
With more clinical trials and seeking FDA approval of national distribution and administration of their treatment, BZYR is presenting an amazing opportunity with huge upside potential.
Burzynski Research Institute (BRI), a biopharmaceutical company committed to developing treatment for cancer based on genomic and epigenomic principles. Research and developmental efforts are focused on cancer treatment with two pipeline drugs—antineoplastons (ANP) in one Phase III clinical trial and 5 Phase II clinical trials. Two additional Phase III trials are being discussed with the FDA. The ultimate goal of the BRI is to discover, develop, and obtain the FDA’s marketing approval of ANP for the treatment of currently incurable types of cancer with emphasis on malignant brain tumors in adults and children.
About Xtremepicks.com
Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. Xtremepicks.com provide market awareness services for small to mid-cap stocks with daily and special newsletters to keep you informed of the latest movers.
Xtremepicks.com penny stock newsletter is your trading connection and remember to always do your own research, use stop loss orders to protect yourself, and book your profits when in a position to do so.
Xtremepicks.com penny stock newsletter profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do your own due diligence. Xtremepicks did not receive any compensation for IFHR and at times may buy any features in the open market. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved
Directglobalmedia.com
Max Gordon
6479227508
contact@directglobalmedia.com
|
|
|
|
Real Estate News by Sector
|
|
|
|
|
